0837 (0837) Fair Value & Analysis

Consumer Defensive · Market cap HK$1.5B

0 0837 0837 · HK

PriceHK$6.11

Fair ValueHK$13.04

Upside+113.4%

Quality63/100

Evidence: High Range HK$8.43 – HK$16.87

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −12.7% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$5.82 – HK$8.44 · fair‑value band HK$8.43 – HK$16.87 · the HK$6.11 price screens below the HK$13.04 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0837 (0837) currently trades at HK$6.11, while our model-based Fair Value estimate is HK$13.04 — implying the stock looks roughly 113.4% undervalued today. We read business quality at 63/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 0837 generated revenue of HK$558M at a net margin of 30.6%. Revenue grew 11.5% year over year. It earns a return on equity of 18.5%. The balance sheet holds a net cash position of HK$59.0M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$558M

Revenue growth (YoY) +11.5%

Net margin 30.6%

Return on equity 18.5%

Free cash flow HK$155M FY2025

P/E ratio 7.7

More key figures

Operating margin 29.5%

EPS (TTM) HK$0.4400

Dividend yield 5.7%

EPS growth (YoY) -17.4%

Net cash HK$59.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0837 reported revenue of HK$558M in FY2025 versus HK$331M in FY2021, a compound +14.0%/yr. Reported net income was HK$171M in FY2025, compounding +12.3%/yr from FY2021.

Revenue +14.0%/yr

FY21 HK$331M

FY22 HK$348M

FY23 HK$500M

FY24 HK$505M

FY25 HK$558M

Net income +12.3%/yr

FY21 HK$108M

FY22 HK$107M

FY23 HK$174M

FY24 HK$171M

FY25 HK$171M

Is 0837 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
The Procter & Gamble Company PG	2,590 MXN	1,732 MXN	-33%
L'Oréal S.A LRLCF	$450.56	$209.17	-54%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.98	€55.96	-30%
Hindustan Unilever Limited HINDUNILVR	₹2,170	₹807.38	-63%
Reckitt Benckiser Group RBGLY	$12.32	$17.37	+41%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0837 (0837) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$13.04 versus a price of HK$6.11 — about +113% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0837?

Our model-based fair value for 0837 is HK$13.04 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$6.11.

What is the quality score of 0837?

0837 has a Quality Score of 63/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0837 (0837)?

0837 reported trailing-twelve-month revenue of about HK$558M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0837?

The net profit margin of 0837 is about 30.6%, meaning it keeps roughly 30.6% of revenue as net income. Based on the latest reported figures.

Does 0837 pay a dividend?

0837 currently shows a dividend yield of about 5.71% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.